Cation exchange was performed on up-conversion NaYF4:Yb,Tm nanoparticles, resulting in NaYF4:Yb,Tm-NaGdF4 core–shell nanoparticles as indicated by electron energy-loss spectroscopy 2D mapping. Results show that core–shell nanoparticles with a thin, tunable, and uniform shell of subnanometer thickness can be made via this cation exchange process. The resulting NaYF4:Yb,Tm-NaGdF4 core–shell nanoparticles have an enhanced up-conversion intensity relative to the initial core nanoparticles. As potential magnetic resonance imaging (MRI) contrast agents, they were tested for their proton relaxivities. The r1 relaxivity per Gd3+ ion of the nanoparticles with a thin NaGdF4 shell (ca. 0.6 nm thick) measured at 9.4 T was found to be 2.33 mM–1·s–1. This r1 relaxivity is among the highest in all the reported NaYF4–NaGdF4 core–shell nanoparticles. The r1 relaxivity per nanoparticle is 1.56 × 104 mM–1·s–1, which is over 4000 times higher than commercial Gd3+-complexes. The very high proton relaxivity per nanoparticle is critical for targeted MRI as such nanoparticles provide strong contrast even in low concentrations. The presented cation exchange method is a promising way to manufacture core–shell nanoparticles with up-conversion NaYF4:Yb,Tm core and paramagnetic NaGdF4 shell for bimodal imaging, i.e. MR and optical imaging.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: